Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles

被引:32
作者
Brouwer, Philip J. M. [1 ]
Antanasijevic, Aleksandar [2 ]
de Gast, Marlon [1 ]
Allen, Joel D. [3 ]
Bijl, Tom P. L. [1 ]
Yasmeen, Anila [4 ]
Ravichandran, Rashmi [5 ,6 ]
Burger, Judith A. [1 ]
Ozorowski, Gabriel [2 ]
Torres, Jonathan L. [2 ]
LaBranche, Celia [7 ]
Montefiori, David C. [7 ]
Ringe, Rajesh P. [4 ,8 ]
van Gils, Marit J. [1 ]
Moore, John P. [4 ]
Klasse, Per Johan [4 ]
Crispin, Max [3 ]
King, Neil P. [5 ,6 ]
Ward, Andrew B. [2 ]
Sanders, Rogier W. [1 ,4 ]
机构
[1] Univ Amsterdam, Amsterdam Infect & Immun Inst, Amsterdam UMC, Dept Med Microbiol, Amsterdam, Netherlands
[2] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA
[3] Univ Southampton, Sch Biol Sci, Southampton, Hants, England
[4] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
[5] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[6] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA
[7] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[8] Inst Microbial Technol, Chandigarh, India
基金
美国国家卫生研究院;
关键词
D O I
10.1038/s41541-021-00285-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.
引用
收藏
页数:14
相关论文
共 55 条
  • [1] Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens
    Abbott, Robert K.
    Lee, Jeong Hyun
    Menis, Sergey
    Skog, Patrick
    Rossi, Meghan
    Ota, Takayuki
    Kulp, Daniel W.
    Bhullar, Deepika
    Kalyuzhniy, Oleksandr
    Havenar-Daughton, Colin
    Schief, William R.
    Nemazee, David
    Crotty, Shane
    [J]. IMMUNITY, 2018, 48 (01) : 133 - +
  • [2] Structural and functional evaluation ofde novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
    Antanasijevic, Aleksandar
    Ueda, George
    Brouwer, Philip J. M.
    Copps, Jeffrey
    Huang, Deli
    Allen, Joel D.
    Cottrell, Christopher A.
    Yasmeen, Anila
    Sewall, Leigh M.
    Bontjer, Ilja
    Ketas, Thomas J.
    Turner, Hannah L.
    Berndsen, Zachary T.
    Montefiori, David C.
    Klasse, Per Johan
    Crispin, Max
    Nemazee, David
    Moore, John P.
    Sanders, Rogier W.
    King, Neil P.
    Baker, David
    Ward, Andrew B.
    [J]. PLOS PATHOGENS, 2020, 16 (08)
  • [3] Accurate design of megadalton-scale two-component icosahedral protein complexes
    Bale, Jacob B.
    Gonen, Shane
    Liu, Yuxi
    Sheffler, William
    Ellis, Daniel
    Thomas, Chantz
    Cascio, Duilio
    Yeates, Todd O.
    Gonen, Tamir
    King, Neil P.
    Baker, David
    [J]. SCIENCE, 2016, 353 (6297) : 389 - 394
  • [4] Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses
    Bale, Shridhar
    Goebrecht, Geraldine
    Stano, Armando
    Wilson, Richard
    Ota, Takayuki
    Tran, Karen
    Ingale, Jidnyasa
    Zwick, Michael B.
    Wyatt, Richard T.
    [J]. JOURNAL OF VIROLOGY, 2017, 91 (16)
  • [5] Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
    Behrens, Anna-Janina
    Vasiljevic, Snezana
    Pritchard, Laura K.
    Harvey, David J.
    Andev, Rajinder S.
    Krumm, Stefanie A.
    Struwe, Weston B.
    Cupo, Albert
    Kumar, Abhinav
    Zitzmann, Nicole
    Seabright, Gemma E.
    Kramer, Holger B.
    Spencer, Daniel I. R.
    Royle, Louise
    Lee, Jeong Hyun
    Klasse, Per J.
    Burton, Dennis R.
    Wilson, Ian A.
    Ward, Andrew B.
    Sanders, Rogier W.
    Moore, John P.
    Doores, Katie J.
    Crispin, Max
    [J]. CELL REPORTS, 2016, 14 (11): : 2695 - 2706
  • [6] Boyoglu-Barnum S., bioRxiv, V2020, P1, DOI DOI 10.1101/2020.05.30.125179
  • [7] Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
    Brinkkemper, Mitch
    Sliepen, Kwinten
    [J]. VACCINES, 2019, 7 (03)
  • [8] Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
    Brouwer, Philip J. M.
    Antanasijevic, Aleksandar
    Berndsen, Zachary
    Yasmeen, Anila
    Fiala, Brooke
    Bijl, Tom Pl
    Bontjer, Ilja
    Bale, Jacob B.
    Sheffler, William
    Allen, Joel D.
    Schorcht, Anna
    Burgers, Judith A.
    Camacho, Miguel
    Ellis, Daniel
    Cottrell, Christopher A.
    Behrens, Anna-Janina
    Catalano, Marco
    Del Moral-Sanchez, Ivan
    Ketas, Thomas J.
    LaBranche, Celia
    van Gils, Marit J.
    Sliepen, Kwinten
    Stewart, Lance J.
    Crispin, Max
    Montefiori, David C.
    Baker, David
    Moore, John P.
    Klasse, Per Johan
    Ward, Andrew B.
    King, Neil P.
    Sanders, Rogier W.
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [9] Advancing an HIV vaccine; advancing vaccinology
    Burton, Dennis R.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2019, 19 (02) : 77 - 78
  • [10] Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
    Burton, Dennis R.
    Hangartner, Lars
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 34, 2016, 34 : 635 - 659